HLA-G and neuroblastoma: Moreover, levels of both sHLA-E and sHLA-G were higher in metastatic NB than in primary NB, where serum levels of HLA-G in NB patients were prognostic markers for disease relapse [109, 110], suggesting a role in disease progression (Fig. 2).